US Clinical Chemistry and Immunodiagnostic Market 2017-2021 – Exciting Opportunities for Instrument and Reagent Companies – Research and Markets

DUBLIN–(BUSINESS WIRE)–The "US
Clinical Chemistry and Immunodiagnostic Market Supplier Shares and
Segment Forecasts 2017-2021: Emerging Opportunities and Growth
Strategies for Instrument and Reagent Suppliers" report has
been added to ResearchAndMarkets.com's offering.

This new report is a strategic analysis of major business opportunities
emerging in the US clinical chemistry and immunodiagnostic markets
during the next five years.

The clinical chemistry and immunodiagnostic markets are undergoing
significant transformation, caused by convergence of new and more
stringent regulations; advances in diagnostic technologies, system
engineering, automation, and IT; and intensifying competition.

Some segments, like routine chemistry, are already resembling commodity
markets, where product positioning and cost per test are more critical
than underlying technology. This evolving marketplace creates exciting
opportunities for a variety of new instruments, reagent systems, and
auxiliary products, such as specimen preparation devices, controls, and
calibrators.

The report explores future trends in the US market; provides estimates
of the specimen, test and sales volumes, as well as major suppliers'
sales and market shares; compares features of leading analyzers;
profiles key competitors; and identifies specific product and marketing
opportunities emerging during the next five years.

Strategic assessments of major suppliers and emerging market entrants,
including their sales, product portfolios, marketing tactics,
collaborative arrangements and new products in R&D.

Tests Analyzed in the Report:

• Routine Clinical Chemistry
• Therapeutic Drug Monitoring (TDM)
• Endocrine Function
• Tumor Markers and Special Chemistry
• Immunoproteins
• Drugs of Abuse

Market Segmentation Analysis

Comprehensive review of the market dynamics, trends, structure, size,
growth, and key suppliers.

Test volume and sales forecasts for over 100 clinical chemistry, TDM,
endocrine, cancer, immunoprotein and abused drug assays, by market
segment:

• Hospitals
• Commercial/Private Laboratories
• Physician Offices/Group Practices

Companies Mentioned:

• Abbott Laboratories
• AdnaGen/Alere
• Agilent Technologies
• Bayer Healthcare
• Beckman Coulter/Danaher
• Bio-Rad
• Biomedical Diagnostics
• BioMerieux
• DiaSorin
• Eiken
• Fujirebio
• Grifols
• Instrumentation Laboratory
• Kyowa Medex
• Matritech/Alere
• Ortho-Clinical Diagnostics
• Quest Diagnostics
• Roche
• Siemens
• Sysmex
• Thermo Fisher
• Tosoh
• Wako
• Wallac/PE

Key Topics Covered:

I. Introduction

II. Worldwide Market Overview

III. Major Product Development Opportunities

IV. Design Criteria for Decentralized Testing Products

V. Alternative Market Penetration Strategies

VI. Potential Market Entry Barriers and Risks

VII. Worldwide Market and Technology Overview

VIII. U.S.A. Clinical Chemistry and Immunodiagnostics Market

IX. Competitive Assessments

For more information about this report visit https://www.researchandmarkets.com/research/2s27k5/us_clinical?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: In
Vitro Diagnostics